Shantou Meiji Pharmaceuticals

Shantou Meiji Pharmaceutical is a specialized pharmaceutical company based in Shantou, China, operating as a key subsidiary of Japan's Meiji Seika Pharma. Founded in 1989 as a joint venture, the company focuses on the manufacturing and commercialization of anti-infective agents, particularly beta-lactam antibiotics such as cephalosporins and penicillins. Its core product lineup includes well-established brands like Meiact (cefditoren pivoxil), Fosmicin (fosfomycin), and Viccillin (ampicillin), which are distributed across China and various international markets. The company maintains sophisticated production facilities that adhere to global Good Manufacturing Practice (GMP) standards for both active pharmaceutical ingredients (APIs) and finished drug products. As a strategic manufacturing hub for the Meiji Group, it plays a vital role in the global supply chain for essential antibiotics.